The top analyst upgrades, downgrades and other research calls from Monday include Advanced Micro Devices, Amazon.com, Capital One, Costco, Delphi Technologies and Twitter.
The November 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Alexion Pharmaceuticals shares saw a handy gain early on Friday after the New York Times reported that there might be some increasing activist movement in the stock.
Chris Lange It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.
The October 31 short interest data have been compared with the previous report, and short interest in the selected biotech stocks was mixed.
The October 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.
The September 29 short interest data have been compared with the previous report, and short interest in the selected biotech stocks was mixed.
Some of the top biotech stocks could become extremely volatile before and after earnings. These four that may be worth a look for aggressive investors.
24/7 Wall St. has collected several catalysts that are coming up in October for biotech and pharmaceutical companies.
The September 15 short interest data have been compared with the previous report, and short interest in all the selected biotech stocks increased.
The August 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The top analyst upgrades, downgrades and other research calls from Tuesday include Chesapeake Energy, Lululemon Athletica, Oracle, US Steel, Walt Disney and YogaWorks.
The August 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
The July 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
